Mumpsvax

"The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor.

Mumpsvax

PATIENT INFORMATION

The health-care provider should provide the vaccine information required to
be given with each vaccination to the patient, parent or guardian.

The health-care provider should inform the patient, parent or guardian of the
benefits and risks associated with vaccination. For risks associated with vaccination
see WARNINGS, PRECAUTIONS,
ADVERSE REACTIONS.

Patients, parents or guardians should be instructed to report any serious adverse
reactions to their health-care provider who in turn should report such events
to the U.S. Department of Health and Human Services through the Vaccine Adverse
Event Reporting System (VAERS), 1-800-822-7967.32